Navigation Links
available in Medical Technology

Overview of Pixantrone Phase III Clinical Data Presentation at American Society of Clinical Oncology 2009 Annual Meeting Now Available at Clinical Care Options

SEATTLE, June 10 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that a summary of the pixantrone Phase III clinical data that were presented at American Society of Clinical Oncology (ASCO) 2009 Annual Meeting on June 1, 2009 is now available at Cli...

New AAHC Toolkit Available to Optimize Clinical Research Administration

Groundbreaking Product is a Must for Clinical Trials Management WASHINGTON, July 21 /PRNewswire-USNewswire/ -- The Association of Academic Health Centers (AAHC) today launched a new Clinical Trials Administration Toolkit designed to assist academic health center leaders, research administrat...

GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers

Data being made available on NCI Database Could Save Drug Development Time and Capital for Other Research Institutions PHILADELPHIA, June 20 /PRNewswire-FirstCall/ -- Marking another positive step in the collaborative fight against cancer, GlaxoSmithKline (NYSE: GSK ) announced to...

Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15)

SEATTLE, May 9 /PRNewswire-USNewswire/ -- The risk of the two major prostate diseases, cancer and benign prostatic hyperplasia (BPH), can be reduced by changes in lifestyle, such as avoiding smoking, maintaining a normal weight and eating a healthy diet. Alan Kristal, Dr.P.H., associate head o...

Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia

BRIDGEWATER, N.J., March 11 /PRNewswire/ -- The totality of scientific data submitted in recent months to the U.S. Food and Drug Administration (FDA) in preparation for the March 13th Oncologic Drugs Advisory Committee Meeting (ODAC) reaffirms that erythropoiesis-stimulating agents (ESAs) are ...

Merck/Gilead Once-A-Day AIDS Pill Not Available in Most Places - AHF Urges Speed-Up of Registrations

The once-daily HIV treatment would greatly increase effectiveness for patients, but Gilead Sciences and Merck and Co. have failed to register it in countries where it is needed most LOS ANGELES, Sept. 10 /PRNewswire-USNewswire/ -- AIDS Healthcare Foundation (AHF) today calle...

New Resource Available for People With Lymphoma

FAIRFAX, Va., Aug. 2 /PRNewswire-USNewswire/ -- The American Society for Therapeutic Radiology and Oncology has published the brochure Radiation Therapy for Lymphoma, a short treatment guide to assist people coping with Hodgkin's and non-Hodgkin's lymphoma. The brochure outlines the major diff...

BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available

ARLINGTON, Va., May 5 /PRNewswire/ -- BioInformatics, LLC announces the release of its newest report, Capitalizing on New Opportunities for Stem Cell Products. Despite a sluggish economy and cuts being made to laboratory budgets, the market for stem cell research products is expected to increa...

New Gene Methylation Test for Prostate Cancer Available

RARITAN, N.J., May 16 /PRNewswire/ -- Veridex, LLC announced today that its licensing collaborator, Laboratory Corporation of America Holdings (LabCorp), has commercially launched a new gene methylation test for prostate cancer. The new assay uses the biological specificity of 'DNA methylation...

Survival Data Available from Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer

NEW YORK--(BUSINESS WIRE)--Apr 4, 2007 - ImClone Systems Incorporated (NASDAQ: IMCL) and Bristol-Myers Squibb Company (NYSE: BMY) announced today that a first line Phase III study of ERBITUX(R) (Cetuximab) combined with platinum-based chemotherapy met the primary endpoint of increasing overall surv...

Survival Data Available From Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer

-- First large, randomized Phase III study of ERBITUX with chemotherapy in recurrent and/or metastatic head and neck cancer meets primary endpoint of improving overall survival -- NEW YORK, April 04, 2007 /PRNewswire-FirstCall/ -- ImClone Systems Incorporated and Bristol-Myers Squibb Company annou...

Data Available from Erbitux Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer

NEW YORK, April 10, 2007 /PRNewswire-FirstCall/ -- ImClone Systems Incorporated and Bristol-Myers Squibb Company today announced that a Phase III study of ERBITUX(R) (Cetuximab) plus gemcitabine (a chemotherapy) in patients with locally advanced unresectable or metastatic pancreatic cancer did not...

Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study

- Gleevec found to dramatically reduce the risk of cancer returning after surgery for Kit-positive gastrointestinal stromal tumors (GIST) EAST HANOVER, N.J., April 12, 2007 /PRNewswire/ -- Investigators will begin offering Gleevec(R) (imatinib mesylate)* tablets to patients receiving placebo in a ...

Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer

NEW YORK, July 12, 2007 /PRNewswire-FirstCall/ -- ImClone Systems Incorporated and Bristol-Myers Squibb Company today announced results from an open-label Phase III study of ERBITUX(R) (Cetuximab) plus a taxane and carboplatin in the first-line treatment for metastatic non-small cell lung cancer (...

Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA

... that we pursue the vaccine licensure pathway made available to us, while at the same time, continue the import... data, immunogenicity and safety data will be made available through clinical studies. Sanofi Pasteur will test... influenza A(H1N1) 2009 vaccine clinical trials is available at www.clinicaltrials.gov . About sano...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

...x as a single agent for the treatment of EGFR-expressing, metastatic colorectal carcinoma is based on progression-free survival. Currently no data are available that demonstrate an improvement in disease-related symptoms or increased survival with Vectibix. Vectibix has not shown a treatment benefit for patien...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...ipomersen and support our efforts to make the drug available to patients in need," said Ms. Parshall. "... in severe hypercholesterolemia patients should be available at the time of these U.S. submissions and may prov...t www.isispharm.com . A webcast replay will be available for a limited time at the same address. A...

Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis

...apidly, particularly at the femoral neck, since hip fractures are one of the most serious complications of osteoporosis and an area in which currently available osteoporosis treatments are weak." "These data are consistent with the clinical hypothesis for BA058--greater gains in BMD at the critical ana...

NewCardio Announces Master Services Agreement With Dedicated Phase I

...other future events or conditions. These statements are based on current expectations, estimates and projections about our business based on currently available information and assumptions made by management. Although we believe that the assumptions on which the forward-looking statements contained herein are ...

Labopharm files New Drug Submission with Health Canada for novel antidepressant

... molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is now available in 17 countries around the world, including the U.S., Canada, major European markets and Australia. The Company's second product, a novel formulation ...

NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone

...rocess from gene sequence to cGMP manufacturing is available on the Novavax website (www.Novavax.com). ...s around the world by addressing gaps in currently available vaccine technologies," added Dr. Rahul Singhvi, Pr...proaches. Additional information about Novavax is available at www.novavax.com and in the company's various fi...

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

...al: (866) 831-6270 (U.S.); (617) 213-8858 (international) Passcode: 25099763 (Howard Robin is the host) An audio replay will also be available shortly following the call through Wednesday, August 19, 2009 and can be accessed by dialing (888) 286-8010 (U.S.); or (617) 801-6888 (international) ...

Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930

...validation of Mercury's technology and of the growing appreciation of AMPK as a novel drug target for metabolic diseases. The development of an orally available direct activator of AMPK has the potential to be a first-in-class therapeutic for type 2 diabetes, hyperlipidemia, and a number of indications in onco...

Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome

...d Severe Chronic Idiopathic Neutropenia. Reprints of both publications are available from Telik. Background on MDS and TELINTRA MDS is a heterog... death in human leukemia cell lines. Additional information on TELINTRA is available at www.telik.com . About Telik Telik, Inc. of Palo Alto,...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

...r this use in the U.S. INVEGA(R) SUSTENNA(TM) is available in milligrams (mg) of paliperidone palmitate in do...oorly water-soluble compounds. More information is available at www.elandrugtechnologies.com . (This pr...this Form 10-K, as well as subsequent filings, are available online at www.sec.gov , www.jnj.com or on reque...

Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program

...h other chemotherapies. Access recently announced data from a recurrent ovarian cancer trial that showed that ProLindac was more active than currently available platinum drugs in that patient population, and that the drug was very well tolerated. ProLindac is a novel DACH platinum drug that has shown to...

Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA

...ently with the FDA and other regulatory agencies to make velaglucerase alfa available as soon as possible to help meet the needs of the Gaucher community." ...or Type 1 Gaucher patients. The prospect of having another treatment option available to help patients achieve therapeutic goals is very important and is welcome...

OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer

... disease progression, and six patients were alive at time of data presentation. Median progression free survival was 3.3 months. This poster is available at www.celltherapeutics.com/investor_updates About (product) OPAXIO(TM) (paclitaxel poliglumex, CT-2103), which was formerly known as XYOTA...

John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden

...t, because I know the money generated will go directly to help get medicine to those who need it." Tickets to this exclusive (RED)ZONE area are available by visiting www.johnlegend.com/red and entering the special access code as prompted - tickets are $66.00 each and are subject to limited availabil...

Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C

...estors may listen to the call by dialing (888) 806-6208 from locations in the U.S. and (913) 312-0640 from outside the U.S. The webcast replay will be available for at least 72 hours following the call. About PSI-7851 PSI-7851 is a uridine nucleotide analog currently in development for the treatment...

FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia

..., including more than two million people in the United States and more than four million people in Europe. Although there are a number of medications available for patients, treatment success for any antipsychotic agent can be unpredictable because patients often respond differently to various medications. A...

Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk

...ing the estrogen receptors in the breast cells and can reduce the risk of a breast cancer recurrence by up to 50 percent. It's the only anti-estrogen available for prevention of breast cancer recurrence in pre-menopausal women and is one of several anti-estrogens used to treat post-menopausal breast cancer pa...

Is Your Hair Taking a Break?

...own to be very effective in women as well. Both the 2% and 5% solutions are available over-the-counter. While minoxidil does not grow new hair, it works by prolo...d by their hair loss can find help through the many support groups that are available to patients on the Internet. Headquartered in Schaumburg, Ill., the...

Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease

...ional education and research. More information is available at www.nof.org . Society for Women's H...sis and treatment of disease. More information is available at www.womenshealthresearch.org . Amer...cacy, education and research. More information is available at www.aauw.org . American Business Wo...

Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis

...cluding MAESTRO-02 and MAESTRO-03 - and review the available data from these studies. MAESTRO-02 is an open-lab...h our clinical team to evaluate these data and the available data from MAESTRO-02 and MAESTRO-03 to determine o...ut relapses(vii). There are few treatment options available for these patients(viii). About Lilly ...

Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms

...pressed in the referenced publication. The Phase 3 clinical trial data presented and published to date reflect only a portion of the totality of data available from Phase 3 studies of BZA/CE and, accordingly, do not represent the totality of data and other information that may affect regulatory review and com...

Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skin's Natural Moisture

...re, Sensitive Skin and Gentle Exfoliating variants. The body washes will be available in August 2009 at food, drug, mass and club retailers. For more information...anti-perspirant/deodorants, body mists, hair care and styling aids. Dove is available nationwide in food, drug and mass outlet stores. About Unilever ...

Cyberonics Provides Update on Depression Post-Approval Study

... Additional information on Cyberonics, Inc. and VNS Therapy(TM) is available at www.cyberonics.com and www.vnstherapy.com. Safe harbor statem...ements contained in this press release are based upon information presently available to us and assumptions that we believe to be reasonable. We are not assumin...

Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System

...wed for a total of five years. The Anaconda system is commercially available outside the U.S. where it has been implanted in nearly 4000 patients. It r...cal repair and endovascular repair. Endovascular repair using commercially available devices has been associated with shorter recovery times, reduced hospital s...

R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent

...rtilage and bone. Rigel's R788 is a novel, orally available syk kinase inhibitor designed to interrupt the cel...resentation related to the TASKi3 trial results is available on Rigel's website homepage at http://www.rigel.co...e passcode 13318888. A replay of the call will be available at approximately 10:00 pm EDT/7:00 pm PDT on July ...
Other Tags
(Date:11/18/2014)... Nov. 17, 2014   News ... collaborate to develop The Partners Data Lake, an ... Partners Data Lake will allow researcher and clinicians ... treatment and the lives of patients , ... clinical activities across the Partners system, breaking down ...
(Date:11/18/2014)... NEW YORK , Nov. 18, 2014 /PRNewswire/ ... iris-based identity authentication solutions, and MorphoTrust USA ... solutions and services, today announced a strategic partnership ... across enterprise, motor vehicle administration (MVA), airport screening ... leader in identity-related solutions, MorphoTrust serves consumers through ...
(Date:11/12/2014)... 2014 Crossmatch™, a leading provider of biometric ... fingerprint readers have been deployed throughout Montparnasse Pasteleria, ... Mexico . The bakery chain implemented the Crossmatch ... caused by employees clocking in for each other. ... Montparnasse relied on paper timecards and a mechanical time ...
Breaking Biology News(10 mins):Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2
(Date:11/21/2014)... (PRWEB) November 21, 2014 Porcelain ... picture-perfect smiles for patients in preparation for the coming ... the fronts of teeth, look completely natural, and can ... situations, veneers are also valued for their ability to ... and can be used on one or several teeth ...
(Date:11/21/2014)... 20, 2014 (HealthDay News) -- Seeking to make it ... Food and Drug Administration on Thursday approved a new ... Hydrocodone -- best known by the brand name Vicodin ... tied to a surge in dangerous addictions across the ... Hysingla ER (hydrocodone bitartrate) is an extended-release tablet to ...
(Date:11/21/2014)... 20, 2014 (HealthDay News) -- Certain genes might prevent ... to a fifth of people with type 2 diabetes, ... been pondered by doctors working with diabetic patients, one ... under the impression that exercise helps decrease insulin resistance ... Pena, director of the Center for Weight Management at ...
(Date:11/21/2014)... 21, 2014 Richard Wolfe, co-founder ... will present advanced benefits administration strategies during the ... HR Leadership Summit. This Game Changer breakout session ... to present cutting-edge solutions and best practices to ... how real-time data exchange between health and welfare ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 Center for ... workshops titled “Massachusetts Insurance Funding for Autism Workshops” to ... navigate their way through the insurance coverage process. ... Massachusetts law and the most effective ways to access ... Dec. 4 from 6-8:00 p.m. at 331 Montvale Ave., ...
Breaking Medicine News(10 mins):Health News:Los Angeles Porcelain Veneers Dentist, Dr. Kevin Sands, Now Creates Picture-Perfect Smiles for Patients for the Holiday Season 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 3Health News:Exercise Might Not Help Some Type 2 Diabetics Control Their Blood Sugar 2Health News:Exercise Might Not Help Some Type 2 Diabetics Control Their Blood Sugar 3Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 3Health News:Center for Autism and Related Disorders to Host Massachusetts Autism Insurance Workshops for Parents 2
Other Contents